Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1992 1
1993 1
1995 1
1997 1
1999 2
2001 5
2002 4
2003 4
2004 5
2005 2
2006 2
2007 2
2008 2
2009 5
2010 9
2011 9
2012 6
2013 6
2014 8
2015 6
2016 4
2017 4
2018 2
2019 1
2020 4
2021 8
2022 5
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM. Aguilar-Guisado M, et al. Among authors: espigado i. Lancet Haematol. 2017 Dec;4(12):e573-e583. doi: 10.1016/S2352-3026(17)30211-9. Epub 2017 Nov 15. Lancet Haematol. 2017. PMID: 29153975 Clinical Trial.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Pagano L, Salmanton-García J, Marchesi F, Blennow O, Gomes da Silva M, Glenthøj A, van Doesum J, Bilgin YM, López-García A, Itri F, Nunes Rodrigues R, Weinbergerová B, Farina F, Dragonetti G, Berg Venemyr C, van Praet J, Jaksic O, Valković T, Falces-Romero I, Martín-Pérez S, Jiménez M, Dávila-Valls J, Schönlein M, Ammatuna E, Meers S, Delia M, Stojanoski Z, Nordlander A, Lahmer T, Imre Pinczés L, Buquicchio C, Piukovics K, Ormazabal-Vélez I, Fracchiolla N, Samarkos M, Méndez GA, Hernández-Rivas JÁ, Espigado I, Cernan M, Petzer V, Lamure S, di Blasi R, Marques de Almedia J, Dargenio M, Biernat MM, Sciumè M, de Ramón C, de Jonge N, Batinić J, Aujayeb A, Marchetti M, Fouquet G, Fernández N, Zambrotta G, Sacchi MV, Guidetti A, Demirkan F, Prezioso L, Ráčil Z, Nucci M, Mladenović M, Liévin R, Hanáková M, Gräfe S, Sili U, Machado M, Cattaneo C, Adžić-Vukičević T, Verga L, Labrador J, Rahimli L, Bonanni M, Passamonti F, Pagliuca A, Corradini P, Hoenigl M, Koehler P, Busca A, Cornely OA. Pagano L, et al. Among authors: espigado i. Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257. Blood. 2022. PMID: 36126318 Free PMC article.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Marchesi F, Salmanton-García J, Emarah Z, Piukovics K, Nucci M, López-García A, Ráčil Z, Farina F, Popova M, Zompi S, Audisio E, Ledoux MP, Verga L, Weinbergerová B, Szotkovski T, Da Silva MG, Fracchiolla N, De Jonge N, Collins G, Marchetti M, Magliano G, García-Vidal C, Biernat MM, Van Doesum J, Machado M, Demirkan F, Al-Khabori M, Žák P, Víšek B, Stoma I, Méndez GA, Maertens J, Khanna N, Espigado I, Dragonetti G, Fianchi L, Del Principe MI, Cabirta A, Ormazabal-Vélez I, Jaksic O, Buquicchio C, Bonuomo V, Batinić J, Omrani AS, Lamure S, Finizio O, Fernández N, Falces-Romero I, Blennow O, Bergantim R, Ali N, Win S, Van Praet J, Tisi MC, Shirinova A, Schönlein M, Prattes J, Piedimonte M, Petzer V, Navrátil M, Kulasekararaj A, Jindra P, Sramek J, Glenthøj A, Fazzi R, De Ramón-Sánchez C, Cattaneo C, Calbacho M, Bahr NC, El-Ashwah S, Cordoba R, Hanakova M, Zambrotta G, Sciumè M, Booth S, Rodrigues RN, Sacchi MV, García-Poutón N, Martín-González JA, Khostelidi S, Gräfe S, Rahimli L, Ammatuna E, Busca A, Corradini P, Hoenigl M, Klimko N, Koehler P, Pagliuca A, Passamonti F, Cornely OA, Pagano L; EPICOVIDEHA working group. Marchesi F, et al. Among authors: espigado i. Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847. Haematologica. 2023. PMID: 35545919 Free PMC article.
Antifungal combination therapy for invasive aspergillosis.
Martín-Peña A, Aguilar-Guisado M, Espigado I, Cisneros JM. Martín-Peña A, et al. Among authors: espigado i. Clin Infect Dis. 2014 Nov 15;59(10):1437-45. doi: 10.1093/cid/ciu581. Epub 2014 Jul 21. Clin Infect Dis. 2014. PMID: 25048847 Review.
[Empirical antifungal therapy in selected patients with persistent fever and neutropenia].
Cisneros JM, Espigado I, Rivero A, Lozano de León F, Parra J, Collado AR, Lomas JM, Pachón J; Sociedad Andaluza de Enfermedades Infecciosas. Cisneros JM, et al. Among authors: espigado i. Enferm Infecc Microbiol Clin. 2005 Dec;23(10):609-14. doi: 10.1016/s0213-005x(05)75041-2. Enferm Infecc Microbiol Clin. 2005. PMID: 16324551 Review. Spanish.
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Salmanton-García J, Marchesi F, Glenthøj A, Bilgin YM, van Praet J, Dávila-Valls J, Martín-Pérez S, Labrador J, van Doesum J, Falces-Romero I, Farina F, Schönlein M, Chanut M, Petzer V, Espigado I, Dargenio M, Aujayeb A, Sili U, Serrano L, Pinczés LI, de Jonge N, Soto-Silva A, Buquicchio C, Prezioso L, Marchetti M, Meers S, Busca A, Corradini P, Hoenigl M, Koehler P, Rahimli L, Çolak GM, Arellano E, Wolf D, Gräfe S, Ammatuna E, Berg Venemyr C, Cornely OA, Pagano L. Salmanton-García J, et al. Among authors: espigado i. Hemasphere. 2022 Oct 25;6(11):e789. doi: 10.1097/HS9.0000000000000789. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36310756 Free PMC article. No abstract available.
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Piñana JL, Martino R, García-García I, Parody R, Morales MD, Benzo G, Gómez-Catalan I, Coll R, De La Fuente I, Luna A, Merchán B, Chinea A, de Miguel D, Serrano A, Pérez C, Diaz C, Lopez JL, Saez AJ, Bailen R, Zudaire T, Martínez D, Jurado M, Calbacho M, Vázquez L, Garcia-Cadenas I, Fox L, Pimentel AI, Bautista G, Nieto A, Fernandez P, Vallejo JC, Solano C, Valero M, Espigado I, Saldaña R, Sisinni L, Ribera JM, Jimenez MJ, Trabazo M, Gonzalez-Vicent M, Fernández N, Talarn C, Montoya MC, Cedillo A, Sureda A; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH). Piñana JL, et al. Among authors: espigado i. Exp Hematol Oncol. 2020 Aug 25;9:21. doi: 10.1186/s40164-020-00177-z. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32864192 Free PMC article.
T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients.
Sánchez-Céspedes J, Marrugal-Lorenzo JA, Martín-Gandul C, Rodríguez-Torres N, Montero-Mateos E, Serna-Gallego A, Escamilla-Gómez V, Merino L, Espigado I, Pachón J, Pérez-Simón JA, Aguilar-Guisado M. Sánchez-Céspedes J, et al. Among authors: espigado i. Haematologica. 2021 Jan 1;106(1):275-278. doi: 10.3324/haematol.2019.240101. Haematologica. 2021. PMID: 31974194 Free PMC article. No abstract available.
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.
Falantes JF, Márquez-Malaver FJ, Carrillo E, Culebras MG, Morales R, Prats C, Vargas MT, Caballero T, Rodríguez-Arbolí E, Espigado I, Pérez-Simón JA. Falantes JF, et al. Among authors: espigado i. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1059-e1066. doi: 10.1016/j.clml.2022.08.012. Epub 2022 Aug 27. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36117041
100 results